Perceptive Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-226,760
| Closed | -$28.5M | – | 166 |
|
|
2021
Q2 | $28.5M | Buy |
+226,760
| New | +$28.5M | 0.37% | 63 |
|
|
2020
Q2 | – | Sell |
-6,813
| Closed | -$583K | – | 144 |
|
|
2020
Q1 | $583K | Buy |
+6,813
| New | +$583K | 0.02% | 99 |
|
|
2019
Q1 | – | Sell |
-905,017
| Closed | -$39.9M | – | 121 |
|
|
2018
Q4 | $39.9M | Sell |
905,017
-623,188
| -41% | -$27.5M | 1.52% | 21 |
|
|
2018
Q3 | $87.5M | Hold |
1,528,205
| – | – | 2.34% | 7 |
|
|
2018
Q2 | $74.1M | Buy |
1,528,205
+11,946
| +0.8% | +$580K | 1.94% | 11 |
|
|
2018
Q1 | $59.3M | Sell |
1,516,259
-100,000
| -6% | -$3.91M | 1.66% | 18 |
|
|
2017
Q4 | $68.6M | Hold |
1,616,259
| – | – | 2.27% | 10 |
|
|
2017
Q3 | $60.3M | Buy |
1,616,259
+905,000
| +127% | +$33.8M | 2.3% | 11 |
|
|
2017
Q2 | $21.6M | Buy |
711,259
+47,402
| +7% | +$1.44M | 1.09% | 26 |
|
|
2017
Q1 | $17.6M | Buy |
663,857
+43,870
| +7% | +$1.16M | 1% | 31 |
|
|
2016
Q4 | $15.8M | Buy |
619,987
+30,097
| +5% | +$768K | 1.13% | 23 |
|
|
2016
Q3 | $21.3M | Sell |
589,890
-13,146
| -2% | -$476K | 1.38% | 13 |
|
|
2016
Q2 | $20.5M | Sell |
603,036
-200,000
| -25% | -$6.8M | 1.42% | 15 |
|
|
2016
Q1 | $21.2M | Buy |
803,036
+527,000
| +191% | +$13.9M | 1.86% | 9 |
|
|
2015
Q4 | $13.5M | Hold |
276,036
| – | – | 1% | 24 |
|
|
2015
Q3 | $6.87M | Hold |
276,036
| – | – | 0.55% | 38 |
|
|
2015
Q2 | $8.73M | Sell |
276,036
-60,000
| -18% | -$1.9M | 0.53% | 40 |
|
|
2015
Q1 | $12.8M | Buy |
336,036
+18,400
| +6% | +$700K | 0.99% | 26 |
|
|
2014
Q4 | $12.4M | Sell |
317,636
-127,364
| -29% | -$4.96M | 1.04% | 27 |
|
|
2014
Q3 | $13.5M | Buy |
445,000
+145,000
| +48% | +$4.38M | 1.36% | 22 |
|
|
2014
Q2 | $10.2M | Buy |
+300,000
| New | +$10.2M | 1% | 31 |
|